PMID: 9544234Apr 17, 1998Paper

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors

Human Immunology
I KawashimaE Celis

Abstract

One approach to development of specific cancer immunotherapy relies on the induction of cytotoxic T lymphocytes (CTL) specific for tumor-associated antigens (TAA). Induction of TAA-specific CTL could be used towards the eradication of established tumors, or to prevent their dissemination or recurrence after primary treatment. The present study identifies a set of CTL epitopes from TAA frequently found on solid epithelial tumors such as breast, lung and gastro-intestinal tumors. Specifically, HLA-A2.1 binding peptides from the MAGE2, MAGE3, HER-2/neu and CEA antigens were tested for their capacity to elicit in vitro anti-tumor CTL using lymphocytes from normal volunteers and autologous dendritic cells as antigen-presenting cells. A total of 6 new epitopes (MAGE2[10(157)], MAGE3[9(112)], CEA[9(691)], CEA[9(24)], HER2[9(435)] and HER2[9(5)]) were identified which were capable of specifically recognizing tumor cell lines lines expressing HLA-A2.1 and the corresponding TAA. In one case (CEA[9(24)]), induction of vigorous anti-tumor CTL responses required epitope engineering to increase HLA-A2.1 binding affinity. Finally, most of the newly identified epitopes (5 out of 6) were found to be highly crossreactive with other common HLA al...Continue Reading

References

May 1, 1978·Obstetrics and Gynecology·K E Kjorstad, H Orjaseter
May 14, 1992·The New England Journal of Medicine·A J Levine
Apr 1, 1991·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·H G LeuschC Wagener
Jul 5, 1991·Science·M HollsteinC C Harris
Jan 1, 1991·Journal of Clinical Laboratory Analysis·J A ThompsonW Zimmermann
Jun 6, 1991·Nature·A J LevineC A Finlay
Jan 1, 1989·Annual Review of Immunology·A Townsend, H Bodmer
Jan 1, 1985·Critical Reviews in Oncology/hematology·J E Shively, J D Beatty
Jan 1, 1983·Annual Review of Immunology·M Nabholz, H R MacDonald
Dec 1, 1995·The Journal of Experimental Medicine·P M van EndertJ F Bach
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·E CelisH M Serra
Sep 1, 1994·European Journal of Immunology·P van der BruggenT Boon
Jun 22, 1995·International Journal of Cancer. Journal International Du Cancer·V RussoC Bordignon
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·G E PeoplesT J Eberlein
Jan 1, 1995·Immunogenetics·H G RammenseeS Stevanoviíc
Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Mar 15, 1994·International Journal of Cancer. Journal International Du Cancer·P WeynantsT Boon
Jan 1, 1994·Immunogenetics·C De SmetT Boon
May 14, 1993·Science·A Lanzavecchia
May 1, 1996·The Journal of Experimental Medicine·S L TopalianP F Robbins
Jan 1, 1996·Annual Review of Immunology·I A York, K L Rock
Dec 1, 1995·Seminars in Cancer Biology·E CelisH M Grey
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·M RöpkeM H Claesson
Feb 1, 1997·Immunology Today·S H van der BurgC J Melief
Mar 3, 1997·The Journal of Experimental Medicine·M TheobaldL A Sherman

❮ Previous
Next ❯

Citations

Oct 1, 1998·International Journal of Cancer. Journal International Du Cancer·K KonoR Kiessling
Jan 1, 2005·Cancer Immunology, Immunotherapy : CII·Tobias KrügerStefan Stevanović
Jun 11, 2005·Cancer Immunology, Immunotherapy : CII·Constantin N BaxevanisMichael Papamichail
Jan 26, 2006·Cancer Immunology, Immunotherapy : CII·Kousaku MimuraHideki Fujii
Sep 9, 2006·Cancer Immunology, Immunotherapy : CII·Pedro M S AlvesFrédéric Lévy
Jul 22, 2009·Cancer Immunology, Immunotherapy : CII·Lavakumar KaryampudiKeith L Knutson
Jan 27, 2011·Cancer Metastasis Reviews·Riad Abès, Jean-Luc Teillaud
Nov 25, 2003·Human Immunology·Bing ZhaoPandjassarame Kangueane
Apr 25, 2000·Human Immunology·P KangueaneP R Kolatkar
Sep 2, 1998·Current Opinion in Immunology·A Sette, J Sidney
Sep 5, 2002·Breast Cancer Research and Treatment·Roza K SypniewskaClaudia Gravekamp
Oct 22, 2013·Nature Biotechnology·Christian S Hinrichs, Nicholas P Restifo
Jul 6, 2007·Leukemia·J H Kessler, C J M Melief
Nov 5, 1999·Vox Sanguinis·J G BodmerP I Terasaki
Feb 28, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Cleanthi DimasA Kondis-Pafitis
Feb 4, 2003·Surgery·Yoshiyuki TanakaPeter S Goedegebuure
Jul 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·He ZhouRalph A Reisfeld
Jul 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Denise L DoolanAlessandro Sette
Mar 2, 1999·The Journal of Experimental Medicine·P ChauxP van der Bruggen
May 10, 2006·Immunology and Cell Biology·Sebastien ViattePedro Romero
Jun 3, 2000·Annual Review of Immunology·L Fong, E G Engleman
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria R ParkhurstSteven A Rosenberg
Jan 24, 2008·BMC Immunology·John SidneyAlessandro Sette
Nov 29, 2012·BMC Cancer·Shinji ShimatoDavid E Anderson
Jun 22, 2013·Journal of Translational Medicine·Annelies W TurksmaErik Hooijberg
Apr 12, 2003·The Lancet Oncology·Agnieszka Michael, Hardev S Pandha
Nov 8, 2012·Future Oncology·Jessica A CintoloBrian J Czerniecki
Mar 22, 2001·Tissue Antigens·E S SchultzP van der Bruggen
Feb 10, 2006·Cancer Immunology, Immunotherapy : CII·Saskia J A M SantegoetsTanja D de Gruijl
Nov 26, 2002·Immunological Reviews·Pierre Van Der BruggenThierry Boon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.